Similarly, MycN, a key driver of CNS neural stem cells that is amplified in the neural crest derived pediatric cancer neuroblastoma (236, 237), showed interesting differential activity patterns: while the results show canonical activity in the ventral neural tube, the activity scores were negative in the developing neural crest indicating different roles, which may be of significance for therapeutic planning of neuroblastoma. This evidence concerns the gene MYCN and cancer.